API Division
Introduction of API Division
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
- Categories:原料药事业部
- Time of issue:2018-11-01 00:00:00
- Views:0
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. (FFPC), established in 1979, was 100% acquired by Livzon Pharmaceutical Group Inc. in 2004, with the purpose of developing it into a first–class fermented API production center and research & development (R&D) center.
FFPC has 2 manufacturing sites in Fujian province, which have modern equipment, and advanced fermentation and extraction technologies. The facilities been approved by USFDA and EUGMP and received SGMP and CGMP certifications. The main products produced by FFPC are vancomycin HCl, teicoplanin, milbemycin oxime, and kanamycin acid sulphate. Vancomycin HCl and teicoplanin have obtained CEP certificates, and kanamycin mono sulfate and kanamycin acid sulfate have passed World Health Organization (WHO) inspection.
Introduction of API Division
Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China Tel: 0756-8135888
©2021 Livzon 粤ICP备05025993号 Support:300.cn
Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China
©2021 Livzon 粤ICP备05025993号
Support:300.cn